Search Within

Mariel Elena Boyd

  1. "Biostatistics Service"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (6)
  2. Department of Medicine (6)
  3. Epidemiology and Biostatistics (6)
  4. Genitourinary Oncology Service (6)
  5. Solid Tumor Oncology Division (6)
  6. Department of Pathology and Laboratory Medicine (4)

More Groups

People
  1. Dean Bajorin (6)
  2. Irina Ostrovnaya (6)
  3. Jonathan Rosenberg (6)
  4. Ashley Regazzi (4)
  5. Asia McCoy (4)
  6. Bernard Bochner (4)

More People

Years
  1. 2018 (1)
  2. 2017 (1)
  3. 2016 (2)
  4. 2015 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. Bladder Cancer (1)
  3. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (1)
  3. IOS Press (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma
    Journal Article

    Teo, M. Y.; Bambury, R. M.; Zabor, E. C.; Jordan, E.; Al-Ahmadie, H.; Boyd, M. E.; Bouvier, N.; Mullane, S. A.; Cha, E. K.; Roper, N.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)
    Meeting Abstract

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I study of everolimus in combination with gemcitabine and split-dose cisplatin in advanced urothelial carcinoma
    Journal Article

    Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Voss, M. H.; Apolo, A. B.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; more...
    Bladder Cancer (2016)

    Fulltext@MSK | Save
  • Association of somatic mutations in DNA damage repair (DDR) genes with efficacy of platinum-based chemotherapy in advanced urothelial carcinoma
    Meeting Abstract

    Bambury, R. M.; Jordan, E.; Zabor, E. C.; Bouvier, N.; Al-Ahmadie, H.; Boyd, M. E.; Mullane, S. A.; Cha, E. K.; Ostrovnaya, I.; Hyman, D. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer
    Meeting Abstract

    Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; Bajorin, D. F.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save